| Zacks Company Profile for Amphastar Pharmaceuticals, Inc. (AMPH : NSDQ) |
|
|
| |
| • Company Description |
| Amphastar Pharmaceuticals, Inc. is a specialty pharmaceutical company. It focuses primarily on developing, manufacturing, marketing, and selling generic and proprietary injectable and inhalation products. The company products include Enoxaparin Sodium Injection; Amphadase; Cortrosyn for Injection; and prefilled disposable emergency syringes for crash cart use. Amphastar Pharmaceuticals, Inc. is headquartered in Rancho Cucamonga, California.
Number of Employees: 2,028 |
|
|
| |
| • Price / Volume Information |
| Yesterday's Closing Price: $28.06 |
Daily Weekly Monthly
 |
| 20 Day Moving Average: 409,880 shares |
| Shares Outstanding: 46.49 (millions) |
| Market Capitalization: $1,304.65 (millions) |
| Beta: 0.80 |
| 52 Week High: $53.96 |
| 52 Week Low: $20.39 |
| Short Interest Ratio: |
| |
% Price Change |
% Price Change Relative to S&P 500 |
| 4 Week |
-7.12% |
-8.75% |
| 12 Week |
10.73% |
0.59% |
| Year To Date |
-24.43% |
-31.03% |
|
|
|
|
| |
|
|
| |
| • General Corporate Information |
Officers
Jack Yongfeng Zhang - Chief Executive Officer and President
Mary Z. Luo - Chairman and Chief Operating Officer
William J. Peters - Chief Financial Officer
Jacob Liawatidewi - Executive Vice President
Gayle M. Deflin - Director
|
|
Peer Information
Amphastar Pharmaceuticals, Inc. (BGMR)
Amphastar Pharmaceuticals, Inc. (BBIO)
Amphastar Pharmaceuticals, Inc. (IPAH)
Amphastar Pharmaceuticals, Inc. (BRL)
Amphastar Pharmaceuticals, Inc. (BHC)
Amphastar Pharmaceuticals, Inc. (AKRXQ)
|
|
Industry / Sector / Ticker Info
Analyst Coverage: No
Industry Group: MED-GENERIC DRG
Sector: Medical
CUSIP: 03209R103
SIC: 2834
|
|
Fiscal Year
Fiscal Year End: December
Last Reported Quarter: 06/01/25
Next Expected EPS Date: 11/05/25
|
|
Share - Related Items
Shares Outstanding: 46.49
Most Recent Split Date: (:1)
Beta: 0.80
Market Capitalization: $1,304.65 (millions)
|
|
|
|
|
| |
| • EPS Information |
• Dividend Information |
| Analyst Coverage: No |
Dividend Yield: 0.00% |
| Current Fiscal Quarter EPS Consensus Estimate: $0.80 |
Indicated Annual Dividend: $0.00 |
| Current Fiscal Year EPS Consensus Estimate: $3.09 |
Payout Ratio: 0.00 |
| Number of Estimates in the Fiscal Year Consensus: 3.00 |
Change In Payout Ratio: 0.00 |
| Estmated Long-Term EPS Growth Rate: % |
Last Dividend Paid: NA - $0.00 |
| Next EPS Report Date: 11/05/25 |
|
|
|
| |
